Annual Drug Patent Expirations for EPRONTIA
Eprontia is a drug marketed by Azurity and is included in one NDA. It is available from one supplier. There are three patents protecting this drug.
The generic ingredient in EPRONTIA is topiramate. One supplier is listed for this compound. Additional details are available on the topiramate profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
